This year’s RQA Annual Conference, held in Leeds was attended by over 300 delegates and many attendees visited the ADAMAS stand in the exhibition hall. The Poster by Dr Annie Chen, ADAMAS Consultant “Conducting remote vendor audits” proved extremely popular and repeat...
ADAMAS Consulting started on 1st September 1997 with five full-time auditing staff, based in the UK, but operating globally. ADAMAS’s business goal was “to become the global independent pharmaceutical Quality Assurance service provider of choice” – so how have we...
Mark Poulton recently presented a presentation at an RQA regional forum meeting (Scotland and English Borders, 29-Jan-15) entitled “Audit vs Inspection”. This presentation was intended to awaken minds to the similarities between audits and inspections and to make...
ADAMAS was pleased to have two of its senior staff featured in the July edition of the RQA journal ‘QUASAR’. A professional and personal profile of Dr Christine Henderson, who is a Board Member of RQA and the Quality and Training Director of ADAMAS Consulting, was...
FDA inspectors recently raised concerns over the conduct of multiple trials with the same investigational medicinal product (IMP) under the oversight of the same investigator. A warning letter was issued to one such investigator, as the FDA observed delays in...
Dana Beck, one of our leading Consultants for ADAMAS Consulting in the Americas, was recently honoured by the Society of Quality Assurance and awarded the “Best Poster” accolade at the SQA 2015 Annual Conference held in Tampa, Florida the week of April 12th. Her...
An ADAMAS project refers to the contractual deliverable that is established with a client. This can be a one-off specialised audit or, in some cases, a larger programme of audits. Examples of where ADAMAS has been involved in large projects include instances where...
From Reactive Compliance to Strategic Partnership: How Clinical Quality Is Evolving
RQA 8th Global QA Conference 2026 | London, UK
FDA’s Real-Time Clinical Trial Initiative: Endorses Data-Enabled QA Oversight
SCOPE Europe 2026 | Barcelona, Spain
Beyond Audit Cycles: A Risk-Based Approach to Regulatory Excellence in Pharmacovigilance